When depression continues despite trying medication and therapy, it can become difficult to know what to do next. Some people experience only partial improvement, while others find that several treatments have made little difference to their symptoms. In clinical practice, this may lead to a discussion about treatment-resistant depression and whether a different approach is warranted.
Ketamine has attracted attention as a potential option for people who have not responded adequately to conventional antidepressants. However, understanding when it may be considered requires a closer look at how treatment resistance is defined, what the evidence shows, and why medical supervision matters.
What Is Treatment-Resistant Depression?
Treatment-resistant depression (TRD) generally describes major depressive disorder that has not improved sufficiently despite appropriate treatment. Although definitions vary across research studies and clinical settings, a commonly used criterion is failure to achieve remission after at least two antidepressant trials at adequate doses and durations.
This distinction matters because trying a medication briefly or taking a dose that is too low may not provide a fair assessment of its effectiveness. Clinicians also consider whether the medication was taken consistently and whether side effects prevented a person from completing treatment. Treatment resistance does not mean depression is permanent or that further care will not help. It indicates that the treatment approach may need reassessment.
How Many Failed Medication Trials Count?
In many clinical settings, two antidepressant trials that have not produced sufficient improvement are the starting point for considering treatment-resistant depression. However, the number alone does not determine the diagnosis.
A clinician will usually review several details:
- Medication choice:Which antidepressants were tried, and were they appropriate for the person’s symptoms and circumstances?
- Dose and duration:Was each medication taken at a therapeutic dose for a sufficient period?
- Treatment adherence:Were doses missed, or were side effects responsible for stopping treatment early?
- Degree of improvement:Did symptoms remain unchanged, improve partially, or return after an initial response?
- Other contributing factors:Could another medical condition, substance use, sleep disturbance, or an unrecognized diagnosis be affecting recovery?
Psychotherapy, medication adjustments, combination treatments, and other evidence-based options may still be appropriate. A clinician may also consider treatments such as transcranial magnetic stimulation or electroconvulsive therapy, depending on the person’s symptoms, history, preferences, and clinical needs. The purpose of this assessment is not to make patients repeat treatments indefinitely. It is to establish what has already been tried and identify reasonable next steps.
Why Does Ketamine Enter the Conversation?
Ketamine works differently from conventional antidepressants. It primarily affects the brain’s glutamate signaling system, including NMDA receptors, rather than acting directly on serotonin, norepinephrine, or dopamine pathways in the same way as many standard antidepressants.
Researchers believe its effects on glutamate signaling and related synaptic processes may help explain why ketamine can reduce depressive symptoms relatively quickly in some patients. Ketamine is therefore one option clinicians may discuss after other treatments have not provided adequate relief. It is not automatically the next step after two unsuccessful medications, nor is it appropriate for every patient.
Is At-Home Ketamine Therapy Appropriate?
At-home ketamine treatment may be offered through certain telehealth programs for carefully selected patients. However, remote prescribing does not remove the need for a thorough medical and psychiatric assessment, clear instructions, and ongoing follow-up. Patients should understand the prescribed dose, the required setting, safety precautions, and what to do if adverse effects occur.
They should never take more than prescribed or combine ketamine with alcohol or other sedating substances unless specifically cleared by their clinician. Driving and other activities requiring alertness must be avoided according to the treatment team’s instructions.
What Should You Consider Before Exploring Ketamine?
A useful starting point is an honest review of previous treatments, including medication names, doses, treatment duration, side effects, and the degree of improvement experienced. This information helps a provider assess whether depression has been adequately treated and whether another approach deserves consideration.
Patients should also ask about the evidence supporting the specific formulation being offered, expected benefits, potential risks, monitoring arrangements, and the plan for follow-up care. Treatment should be evaluated through symptom changes and day-to-day functioning, not simply whether a person feels different immediately after a dose. Treatment-resistant depression can make recovery feel uncertain, but it does not eliminate the possibility of improvement.
When depression persists despite conventional treatment, understanding your next options can be an important step toward finding appropriate care. Daytryp RX provides fully online consultations with licensed medical providers who review your treatment history, current symptoms, and individual health needs before determining whether ketamine treatment is appropriate. For patients exploring ketamine therapy from home, this provider-led process offers a way to discuss potential benefits, risks, and treatment requirements without an initial in-person clinic visit. Daytryp RX also offers ketamine troches for depression, subject to medical evaluation and prescription approval.
Patients in Arizona can also ask about their at-home ketamine therapy in Arizona and whether available services meet their needs. For those comparing treatment options, learning about their ketamine nasal spray price and formulation-specific requirements can help guide informed questions for a provider. Contact them.
About the Author
Rowan Mitchell explores the questions that arise when established approaches to mental health no longer seem sufficient. Their writing focuses on explaining complex clinical concepts, examining emerging therapies critically, and helping readers prepare for more informed conversations with healthcare professionals.
